Prosecution Insights
Last updated: October 02, 2026

Amgen Research Munich GmbH

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Amgen Research Munich GmbH has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit. This indicates a focused prosecution effort on a specific technical application, with all activity localized to one administrative group at the patent office.

The busiest examiner, FARRAR, LAUREN PENG, is responsible for 1 pending office action. This figure represents the entirety of the company's active office actions. Because there is only 1 distinct art unit involved, the prosecution is confined to one specialized group. Practitioners should focus on the specific examination tendencies of FARRAR, LAUREN PENG to effectively manage this Medical Devices & Mechanical Engineering filing.

With 1 distinct examiner and 1 distinct art unit, the company's prosecution is streamlined but lacks the diversity of multiple examiner perspectives. The busiest examiner, FARRAR, LAUREN PENG, handles the 1 pending office action, making her the sole arbiter of the company's current patent prospects. Strategy should be developed with a deep understanding of this examiner's past decisions in the Medical Devices & Mechanical Engineering sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FARRAR, LAUREN PENG 1 78.6% +15.5%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18287046 SYSTEMS FOR OUT-PATIENT TREATMENT OF A PATIENT, AND RELATED METHODS FARRAR, LAUREN PENG —

Top Art Units

Art UnitApps
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18287046 SYSTEMS FOR OUT-PATIENT TREATMENT OF A PATIENT, AND RELATED METHODS FARRAR, LAUREN PENG 3783 §103 Final Rejection — Pending Oct 16, 2023

Managing Amgen Research Munich GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month